Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. So What: ...

ELMWOOD PARK, N.J.--(BUSINESS WIRE)--Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) executed a Restitution Agreement with John Littleton, a former vice president in sales. Pursuant to the Agreement ...

BioReference Laboratories Inc. in Elmwood Park acquired the U.S. Ariosa centralized laboratory prenatal testing business from Roche. The Harmony Prenatal Test, Ariosa’s non-invasive prenatal screening ...

Description: Founded in 1981, BioReference Laboratories is a clinical testing laboratory offering a comprehensive menu of services tapped by health care providers interested in the detection, ...

Similar to BioReference's role as the testing provider for the MLS is Back Tournament, BioReference is providing laboratory-based PCR COVID-19 testing as well as point-of-care (rapid) COVID-19 testing ...

Scarlet brings diagnostic service to patients' homes, offices and other preferred locations, delivering an on-demand, safe and convenient diagnostic experience for patients and healthcare providers ...

BioReference Health, formerly known as BioReference Laboratories, and OPKO Health have agreed to pay $9.85 million to resolve alleged violations of the False Claims Act arising from BioReference’s ...

ELMWOOD PARK, N.J., Aug. 16, 2021 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the acquisition of the U.S. Ariosa centralized laboratory ...

ELMWOOD PARK, N.J.--(BUSINESS WIRE)--BioReference Laboratories, Inc. (NASDAQ: BRLI) announced today that it has received a letter from Horizon Blue Cross Blue Shield of New Jersey (Horizon) ...

BioReference Health LLC, formerly known as BioReference Laboratories Inc. (BioReference) and OPKO Health Inc. (OPKO), face a $704,349 government fine for medically unnecessary blood tests. The ...